RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Granite Bio

Granite Bio

Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis.

Latest funding

$30M Series A ·

Led by Novartis Venture Fund · Source: fundraisingfox.com

Funding history ↓
Website: granitebio.com.
LinkedIn: granitebio.
Category: Health and bio.
Sectors: Biotechnology, Therapeutics.
Stage: Series A.
Based in: Basel, Switzerland.
Last round: Apr 25, 2025 · 570 days ago.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredApr 15, 2021 (5 years old)
About Granite Bio

Granite Bio develops first-in-class therapeutic antibodies depleting pathogenic cells with the potential to transform inflammatory and fibrotic diseases.

Funding rounds

DateRoundAmountLeadSource
Series A$30MNNovartis Venture Fundfundraisingfox.com

Timeline

  1. Website created

Founders and team

Investors

Companies like Granite Bio

Other companies backed by Novartis Venture Fund

Novartis Venture Fund portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/granite-bio (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy